Ignite Creation Date:
2024-05-06 @ 7:27 PM
Last Modification Date:
2024-10-26 @ 3:07 PM
Study NCT ID:
NCT06015321
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-08-29
First Post:
2023-08-23
Brief Title:
An Open Label Phase II Study of First-Line Maintenance Enzalutamide Following Docetaxel Plus Androgen-Deprivation Therapy in Patients With Previously-Untreated Metastatic Castration-Naive Prostatic Adenocarcinoma
Sponsor:
Samsung Medical Center
Organization:
Samsung Medical Center
Organization Data
Organization:
Samsung Medical Center
Class:
OTHER
Study ID:
2023-07-103
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Samsung Medical Center
Lead Sponsor Class:
OTHER
Responsible Party:
Sung Hee Lim
Responsible Party Title:
Samsung Medical Center
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Samsung Medical Center
Old Name:
None
Old Organization:
None